Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.


eCase: Treatment of Tardive Dyskinesia Using Valbenazine in a Patient With Schizophrenia

John M. Kane, MD
Released: November 3, 2021
Back Next


This eCase authored by John M. Kane, MD, explores important considerations in the diagnosis and treatment of tardive dyskinesia (TD) in a patient with a history of schizophrenia and atypical antipsychotic use.

To receive CME credit for this activity, please review the entire content of the activity. After reviewing the module, click the “Claim Credit” button on your screen to complete the posttest and evaluation.

Clinical Care Options plans to measure the educational impact of this activity, and some questions in this activity will be asked twice, once prior to the activity and then once again at the end. Your responses will be aggregated for analysis, but your specific responses will not be shared.

Back Next
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant provided by
Neurocrine Biosciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings